[go: up one dir, main page]

DE69738965D1 - Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente - Google Patents

Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente

Info

Publication number
DE69738965D1
DE69738965D1 DE69738965T DE69738965T DE69738965D1 DE 69738965 D1 DE69738965 D1 DE 69738965D1 DE 69738965 T DE69738965 T DE 69738965T DE 69738965 T DE69738965 T DE 69738965T DE 69738965 D1 DE69738965 D1 DE 69738965D1
Authority
DE
Germany
Prior art keywords
drugs
fragments
detoxification
animals treated
description
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69738965T
Other languages
English (en)
Inventor
Ivo Volpato
Bernard Bizzini
Ernst Bernhard Grabitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dox Al Italia SpA
Original Assignee
Dox Al Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dox Al Italia SpA filed Critical Dox Al Italia SpA
Application granted granted Critical
Publication of DE69738965D1 publication Critical patent/DE69738965D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69738965T 1996-06-27 1997-06-26 Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente Expired - Fee Related DE69738965D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI001309A IT1284076B1 (it) 1996-06-27 1996-06-27 Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro
PCT/EP1997/003358 WO1997049732A1 (en) 1996-06-27 1997-06-26 IgG IMMUNOGLOBULINS AND F(ab')2 FRAGMENTS THEREOF, SPECIFIC FOR DRUGS AND METABOLITES THEREOF, AND THEIR USE FOR DETOXIFICATION PURPOSES

Publications (1)

Publication Number Publication Date
DE69738965D1 true DE69738965D1 (de) 2008-10-16

Family

ID=11374491

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738965T Expired - Fee Related DE69738965D1 (de) 1996-06-27 1997-06-26 Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente

Country Status (6)

Country Link
EP (1) EP0934339B1 (de)
AT (1) ATE407149T1 (de)
AU (1) AU3437497A (de)
DE (1) DE69738965D1 (de)
IT (1) IT1284076B1 (de)
WO (1) WO1997049732A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705376D0 (en) * 1997-03-14 1997-04-30 Harris William J Antibody fragment formulations and assay formats for detecting the presence an d concentration of analytes
GB0003360D0 (en) * 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
US7632929B2 (en) 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
AU2001255537A1 (en) * 2000-04-20 2001-11-07 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US6669937B2 (en) * 2000-04-20 2003-12-30 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
ITMI20010347A1 (it) 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
EP1331219A1 (de) * 2002-01-23 2003-07-30 Drug Abuse Sciences, Inc. Neue Amphetaminderivate, dagegen gerichtete Antikörper und diese enthaltende pharmazeutische Zusammensetzungen
EP2032602B1 (de) 2006-06-15 2013-03-27 The Board of Trustees of the University of Arkansas Monoklonale antikörper mit selektiver erkennung von methamphetamin und methamphetaminähnlichen verbindungen
ES2619647T3 (es) 2007-04-20 2017-06-26 Bioventures Llc Compuestos de hapteno y composiciones y usos de los mismos
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN111060690B (zh) * 2019-10-08 2023-07-07 浙江工商大学 一种检测喹乙醇的时间分辨荧光免疫分析试剂盒及其应用
CN111154000A (zh) * 2020-01-16 2020-05-15 新乡学院 一种抗西马特罗单克隆抗体及其应用
CN111269319B (zh) * 2020-02-21 2021-10-29 华南农业大学 一种特异性纳米抗体Nb2F7及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol

Also Published As

Publication number Publication date
IT1284076B1 (it) 1998-05-08
WO1997049732A1 (en) 1997-12-31
ITMI961309A0 (de) 1996-06-27
ATE407149T1 (de) 2008-09-15
ITMI961309A1 (it) 1997-12-27
AU3437497A (en) 1998-01-14
EP0934339A1 (de) 1999-08-11
EP0934339B1 (de) 2008-09-03

Similar Documents

Publication Publication Date Title
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
DE69738965D1 (de) Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente
EP0701571A1 (de) Antikoerperfragmente in therapie
ATE512224T1 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
KR950005327A (ko) 임파구 항원 CD2 및 종양 항원을 인식하는 이특이적 트리거(Trigger) 분자
DE69932084D1 (de) Antikörperfragmente zur lokalen Behandlung von Augenerkrankungen
KR900005995A (ko) 변형 인터류킨-2 및 그의 제조방법
ATE506076T1 (de) Medizinische verwendung von anti-cs1 antikörpern
EP0770628A4 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
DK101888D0 (da) Immunmodulerende midler og anvendelse af disse
DK0433088T3 (da) Monoklonale antistoffer, der reagerer med et humant atheromaassocieret antigen
NO873495D0 (no) Monoklonale antistoffer og peptider egnet for behandling og diagnose av hiv-infeksjoner.
EP0313378A3 (de) Methoden und Zusammensetzungen für vorübergehende Elimination von humoralen immunen Antikörpern
DE60129278D1 (de) Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen
BR0210648A (pt) Variante de uma molécula imunointerativa, anticorpo monoclonal, forma disimunizada de anticorpo monoclonal 3b6, método para a geração de um anticorpo monoclonal desimunizado, molécula de anticorpo desimunizada, anticorpo desimunizado, anticorpo monoclonal de murino variante 3b6 desimunizado, variante de um anticorpo monoclonal de murino 3b6 desimunizado para uso em humanos, método para a detecção de um coágulo sanguìneo em um paciente humano, método para a detecção de um coágulo sanguìneo ou de um seu fragmento de ligação a antìgeno, método para a facilitação da dissolução ou da remoção de um coágulo sanguìneo em um humano, uso de um anticorpo monoclonal derivado de murino variante, e, conjugado
DE68920624D1 (de) Menschlicher monoklonaler Antikörper, Hybridoma, das ihn herstellt, und pharmazeutisches Mittel.
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
BG99074A (bg) Рекомбинантни човешки нiv-неутрализиращи моноклонални антитела за профилактика и лечение на нiv инфекция
DE69636527D1 (de) Antigenes protein aus malassezia
ES2100164T3 (es) Deteccion y tratamiento de infecciones con inmunoconjugado.
Rangel-Santos et al. Effect of heating on the toxic, immunogenic and immunosuppressive activities of Crotalus durissus terrificus venom
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
FI971879L (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
RU96123360A (ru) Способ лечения сепсиса у новорожденных

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee